![glp-1 receptor agonists should be avoided in patients with Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of The role of glucagon-like peptide-1](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1050961973852737)
glp-1 receptor agonists should be avoided in patients with
Shipping Estimate
glp-1 receptor agonists should be avoided in patients with Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of The role of glucagon-like peptide-1
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
![glp-1 receptor agonists should be avoided in patients with Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of The role of glucagon-like peptide-1](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40519-025-01770-z/MediaObjects/40519_2025_1770_Figa_HTML.png)
![glp-1 receptor agonists should be avoided in patients with Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of The role of glucagon-like peptide-1](https://static.wixstatic.com/media/966baf_6c1aec6e92ad4edc9475497a98bba2d1~mv2.jpg/v1/fill/w_960,h_540,al_c,q_85,enc_avif,quality_auto/966baf_6c1aec6e92ad4edc9475497a98bba2d1~mv2.jpg)
![glp-1 receptor agonists should be avoided in patients with Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of The role of glucagon-like peptide-1](https://www.mdpi.com/jcm/jcm-15-03330/article_deploy/html/images/jcm-15-03330-g002-550.jpg)
![glp-1 receptor agonists should be avoided in patients with Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of The role of glucagon-like peptide-1](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41581-025-01036-y/MediaObjects/41581_2025_1036_Fig1_HTML.png)
